Health Catalyst appoints Simeon Kohl CEO
Analysis based on 9 articles · First reported Sep 08, 2026 · Last updated Sep 08, 2026
The CEO transition is a routine leadership change for a small-cap healthcare technology company, likely having limited impact on broader markets. HCAT shares closed 1.17% lower at $1.69 on Friday, reflecting modest investor reaction.
Health Catalyst, Inc. (Nasdaq: HCAT), a healthcare intelligence company, announced on September 8, 2026, that Simeon Ehui has been appointed Chief Executive Officer, President, and a member of the Board of Directors, effective September 14, 2026. Kohl, who brings over 20 years of healthcare experience, previously served as CEO of Performant Healthcare, leading its strategic transformation before its sale to Machinify for approximately $670 million. Ben Albert, the current CEO and President, will transition to Chief Business Officer and step down from the Board effective September 13, 2026. Albert led the divestiture of Vitalware, which enabled the company to retire its approximately $160 million credit facility and strengthen its balance sheet. The leadership change comes as Health Catalyst moves into its next phase, focusing on AI-forward healthcare intelligence technologies. The company has $2.8 billion in documented outcomes.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard